Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update - ScienceDirect

Applying Recent A1C Recommendations in Clinical Practice

T2D Efficacy & Data Jardiance® (empagliflozin) tablets

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update - ScienceDirect

Research_Review_Special_Report_2023_Update_of_NZSSD_Type_2_Guidelines by WBOP PHO - Issuu

Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY® study

ABSTRACTS ADDRM 2022 Nederlands Tijdschrift voor Diabetologie

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

Applying Recent A1C Recommendations in Clinical Practice

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

A1C and Weight Results RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

Frontiers Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study

PDF) A pragmatic randomized clinical trial of insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of ACHIEVE Control